Drug Delivery 1 (SIG)
Timeslot: Wednesday, April 27, 2022 - 1:00pm to 2:30pm
Room: Harborside Ballroom D-E, 4th Floor
The Drug Delivery SIG session will consider abstracts that fall with the broad areas of therapeutic development, formulation, and application testing. Drug delivery from medical devices, tissue engineering scaffolds/hydrogels, films, microparticles, nanoparticles, environmentally responsive materials, and other types of biomaterial assemblies are all invited. Studies testing drug targeting, drug combinations, and drug/cell combinations are all also welcomed to submit. Drug delivery application areas of interest include but are not limited to regenerative medicine/tissue engineering, cell and tissue transplant, cardiovascular stents and other devices, cancer, microbial infection, and autoimmune diseases.
Abstracts will be available for download on April 27, 2022.
1:00:00 PM 30. INVITED SPEAKER: Search- ing an Evaluating Drug Delivery Technologies, - Vincent Ling, PhD, Takeda Pharmaceuticals
1:30:00 PM 31. Amniotic Fluid Stabilized Lipid Nanoparticles for In Utero Intra-amniotic mRNA Delivery, Kelsey Swingle(1)*, William Peranteau, MD(2), Michael Mitchell, PhD(1); (1)University of Pennsylvania, Philadelphia, PA, USA, (2)Children’s Hospital of Philadelphia, Philadelphia, PA, USA
1:45:00 PM WITHDRAWN
2:00:00 PM 33. Helper Lipid Structure Influences Protein Adsorption and Delivery of Lipid Nanoparticles to Spleen and Liver, Rakan El-Mayta*, Michael Mitchell; University of Pennsylvania, Philadelphia, PA, USA
2:15:00 PM 34. Supramolecular Assembly of Therapeutic mRNA Overcame Critical Delivery Efficiency Barrier for Biodegradable Polymer Carriers, Yizong Hu*, Stephany Tzeng, David Wilson, Jinghan Lin, Jordan Green, Hai-Quan Mao, Johns Hopkins University, Baltimore, MD, USA